 Despite the controversial outcomes of clinical trials executed so far , the prevention of & beta;- amyloid ( A & beta ;-RRB- deposition and neurotoxicity by small molecule inhibitors of A & beta; aggregation remains a target intensively pursued in the search of effective drugs for treating Alzheimer & rsquo; s disease ( AD) and related neurodegeneration syndromes<disease><symptom>. As a continuation of previous studies , a series of new 3- ( 2-arylhydrazono) indolin-2-one derivatives was synthesized and assayed , investigating the effects of substitutions on both the indole core and arylhydrazone moiety. Compared with the reference compound